{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:20:19Z","timestamp":1792801219165,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.pnpbp.2008.01.008","type":"journal-article","created":{"date-parts":[[2008,1,20]],"date-time":"2008-01-20T00:51:08Z","timestamp":1200790268000},"page":"1362-1374","source":"Crossref","is-referenced-by-count":86,"title":["A systematic review of off-label uses of memantine for psychiatric disorders"],"prefix":"10.1016","volume":"32","author":[{"given":"Kristina","family":"Zdanys","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh R.","family":"Tampi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pnpbp.2008.01.008_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2174\/1389450054546015","article-title":"The role of newer antiglutamatergic agents as mood-stabilizers in bipolar disorder","volume":"6","author":"Abelli","year":"2005","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbr.2005.11.023","article-title":"Evidence for the involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice","volume":"168","author":"Almeida","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0014-2999(93)90397-Z","article-title":"Anxiolytic-like effects of N-methyl-D-aspartate-associated glycine receptor ligands in the rat potentiated startle test","volume":"250","author":"Anthony","year":"1993","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pnpbp.2008.01.008_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.adt.0000210724.41187.4a","article-title":"Memantine for alcohol dependence: an open-label pilot study","volume":"6","author":"Arias","year":"2007","journal-title":"Addic Disord Treat"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00213-004-1847-1","article-title":"Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive\u2013compulsive disorder: a preliminary study","volume":"174","author":"Arnold","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/jnr.20756","article-title":"Chronic morphine treatment alters expression of N-methyl-D-aspartate receptor subunits in the extended amygdala","volume":"83","author":"Bajo","year":"2006","journal-title":"J Neurosci Res"},{"issue":"6","key":"10.1016\/j.pnpbp.2008.01.008_bib7","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/430454","article-title":"Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT","volume":"76","author":"Barnby","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.pnpbp.2008.01.008_bib8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/archpsyc.1997.01830220085012","article-title":"Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy","volume":"54","author":"Bartha","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-244X-4-24","article-title":"Prospective open-label study of add-on and monotherapy topiramte in civilians with chronic nonhallucinatory posttraumatic stress disorder: a preliminary report","volume":"4","author":"Berlant","year":"2004","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"157","key":"10.1016\/j.pnpbp.2008.01.008_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130100739","article-title":"The NMDA antagonist memantine attenuates the expression of opiod physical dependence in humans","author":"Bisaga","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00213-003-1617-5","article-title":"Acute effects of memantine in combination with alcohol in moderate drinkers","volume":"172","author":"Bisaga","year":"2004","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.01.008_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0376-8716(99)00107-6","article-title":"In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists","volume":"59","author":"Bisaga","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.pnpbp.2008.01.008_bib14","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1517\/13543784.9.10.2233","article-title":"Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders","volume":"9","author":"Bisaga","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF02245123","article-title":"MK-801 produces a reduction in anxiety-related antipredator defensiveness in male and female rats and a gender-dependent increase in locomotor behavior","volume":"108","author":"Blanchard","year":"1992","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib16","first-page":"S91","article-title":"Treatment of post-traumatic stress disorder with phenytoin: an open label pilot study","volume":"29","author":"Bremner","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1037\/0735-7044.106.3.569","article-title":"Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus","volume":"106","author":"Campeau","year":"1992","journal-title":"Behav Neurosci"},{"issue":"37","key":"10.1016\/j.pnpbp.2008.01.008_bib18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1192\/S0007125000293574","article-title":"A glutamatergic deficiency model of schizophrenia","volume":"174","author":"Carlsson","year":"1999","journal-title":"Br J Psychiatry"},{"issue":"4-5","key":"10.1016\/j.pnpbp.2008.01.008_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s007020050076","article-title":"Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate-serotonin interactions for pharmacotherapy","volume":"105","author":"Carlsson","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1345\/aph.1G297","article-title":"Catatonic schizophrenia and the use of memantine","volume":"40","author":"Carpenter","year":"2006","journal-title":"Annals Pharmacother"},{"issue":"2","key":"10.1016\/j.pnpbp.2008.01.008_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/10401230600614710","article-title":"Amantadine and memantine in catatonic schizophrenia","volume":"18","author":"Carroll","year":"2006","journal-title":"Annals Clin Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2008.01.008_bib22","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1300733","article-title":"Glutamartergic dysfunction in OCD","volume":"30","author":"Chakrabarty","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pnpbp.2008.01.008_bib23","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0883073807302611","article-title":"Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial response and maintenance tolerability","volume":"22","author":"Chez","year":"2007","journal-title":"J Child Neurol"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.01.008_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2005.12.003","article-title":"Memantine increases cardiovascular but not behavioral effects of cocaine in methadone-maintained humans","volume":"83","author":"Collins","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"10.1016\/j.pnpbp.2008.01.008_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00008877-199811000-00014","article-title":"The effects of memantine on the subjective, reinforcing, and cardiovascular effects of cocaine in humans","volume":"9","author":"Collins","year":"1998","journal-title":"Behav Pharmacol"},{"issue":"5","key":"10.1016\/j.pnpbp.2008.01.008_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2005.04.043","article-title":"Riluzole augmentation in treatment-resistant obsessive\u2013compulsive disorder: an open-label trial","volume":"58","author":"Coric","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2008.01.008_bib27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1017\/S1092852900010427","article-title":"The role of glutamate in anxiety and related disorders","volume":"10","author":"Cortese","year":"2005","journal-title":"CNS Spectrums"},{"issue":"5","key":"10.1016\/j.pnpbp.2008.01.008_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","article-title":"Brain metabolic alterations in medication-free patients with bipolar disorder","volume":"61","author":"Dager","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2008.01.008_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pnpbp.2004.11.021","article-title":"Topiramate for binge eating disorder","volume":"29","author":"De Bernardi","year":"2005","journal-title":"Prog Neuropsychopharmacol & Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2008.01.008_bib30","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4088\/JCP.v67n0619h","article-title":"Memantine for disruptive behavior in autistic disorder","volume":"67","author":"Erickson","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-006-0518-9","article-title":"A retrospective study of memantine in children and adolescents with pervasive developmental disorders","volume":"191","author":"Erickson","year":"2007","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.pnpbp.2008.01.008_bib32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1530-0277.2007.00360.x","article-title":"A pilot double-blind treatment trial of memantine for alcohol dependence","volume":"31","author":"Evans","year":"2007","journal-title":"Alcoholism: Clin Exp Res"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.01.008_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(96)00749-2","article-title":"NMDA receptors in the pontine brainstem are necessary for fear potentiation of the startle response","volume":"318","author":"Fendt","year":"1996","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WNF.0b013e3180314ae7","article-title":"An open-label, flexible-dose study of memantine in major depressive disorder","volume":"30","author":"Ferguson","year":"2007","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.01.008_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/cap.2006.0044","article-title":"A pilot evaluation of the safety, tolerability, pharmacokinetics, and effectiveness of memantine in pediatric patients with attention-deficit\/hyperactivity disorder combined type","volume":"17","author":"Findling","year":"2007","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddm283","article-title":"Smoking and alcoholism target genes associated with plasticity and glutamate transmission in the human ventral tegmental area","author":"Flatscher-Bader","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.pnpbp.2008.01.008_bib37","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.01.008_bib38","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","article-title":"Increased levels of glutamate in brains from patients with mood disorders","volume":"62","author":"Hashimoto","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S1461145702003061","article-title":"Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder","volume":"5","author":"Heresco-Levy","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ehb.2005.04.001","article-title":"A new anti-obesity drug treatment: first clinical evidence that, antagonizing glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders","volume":"3","author":"Hermanussen","year":"2005","journal-title":"Econ Hum Biol"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib41","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(96)00670-X","article-title":"Evidence for alcohol anti-craving properties of memantine","volume":"314","author":"Holter","year":"1996","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib42","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/sj.mp.4000979","article-title":"Linkage and association of the glutamate receptor 6 gene with autism","volume":"7","author":"Jamain","year":"2002","journal-title":"Mol Psychiatry"},{"issue":"1-2","key":"10.1016\/j.pnpbp.2008.01.008_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0006-8993(09)90003-8","article-title":"A dopaminergic\u2013glutamatergic basis for the action of amphetamine and cocaine","volume":"658","author":"Karler","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2007.08.001","article-title":"The effects of extinction training in reducing the reinstatement of drug-seeking behavior: involvement of NMDA receptors","volume":"185","author":"Kelamangalath","year":"2007","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.pnpbp.2008.01.008_bib45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00004583-200106000-00010","article-title":"Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder","volume":"40","author":"King","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.01.008_bib46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.pbb.2006.08.005","article-title":"Nicotine and smoker status moderate brain electric and mood activation induced by ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist","volume":"85","author":"Knott","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.01.008_bib47","first-page":"47","article-title":"NMDA antagonists inhibit the development of ethanol dependence in rats","volume":"53","author":"Kotlinska","year":"2001","journal-title":"Pol J Pharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00132576-200211000-00006","article-title":"A pilot study of memantine effects on protracted withdrawal (syndrome of anhedonia) in heroin addicts","volume":"1","author":"Krupitsky","year":"2002","journal-title":"Addict Disord Treat"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1176\/appi.ajp.164.3.519","article-title":"Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients","volume":"164","author":"Krupitsky","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib50","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1530-0277.2007.00344.x","article-title":"Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam","volume":"31","author":"Krupitsky","year":"2007","journal-title":"Alcoholism: Clin Exp Res"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib51","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1196\/annals.1300.010","article-title":"NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy","volume":"1003","author":"Krystal","year":"2003","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.01.008_bib52","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0163-7258(03)00054-8","article-title":"N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability","volume":"99","author":"Krystal","year":"2003","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.pnpbp.2008.01.008_bib53","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1017\/S1092852900010403","article-title":"Beyond monoamines: glutamatergic function in mood disorders","volume":"10","author":"Kugaya","year":"2005","journal-title":"CNS Spectrums"},{"issue":"2","key":"10.1016\/j.pnpbp.2008.01.008_bib54","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00213-005-0246-6","article-title":"N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive\u2013compulsive disorder","volume":"184","author":"Lafleur","year":"2006","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib55","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0887-8994(96)00218-4","article-title":"High levels of cerebrospinal fluid glutamate in Rett syndrome","volume":"15","author":"Lappalainen","year":"1996","journal-title":"Pediatr Neurol"},{"issue":"S","key":"10.1016\/j.pnpbp.2008.01.008_bib56","first-page":"61","article-title":"Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurological disorders","volume":"6","author":"Lipton","year":"2004","journal-title":"J Alzheimer's Dis"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib57","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1073858406298918","article-title":"Neurotransmitters and brain maturation: early paracrine actions of GABA and glutamate modulate neuronal migration","volume":"13","author":"Manent","year":"2007","journal-title":"Neuroscientist"},{"issue":"2","key":"10.1016\/j.pnpbp.2008.01.008_bib58","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0896-6273(00)00042-8","article-title":"Long-term potentiation of excitatory inputs to brain reward areas by nicotine","volume":"27","author":"Mansvelder","year":"2000","journal-title":"Neuron"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2008.01.008_bib59","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.schres.2006.02.001","article-title":"N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels","volume":"84","author":"Martucci","year":"2006","journal-title":"Schizophr Res"},{"issue":"12","key":"10.1016\/j.pnpbp.2008.01.008_bib60","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1176\/appi.ajp.162.12.2379","article-title":"Open-label trial of riluzole in generalized anxiety disorder","volume":"162","author":"Mathew","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"Suppl 4","key":"10.1016\/j.pnpbp.2008.01.008_bib61","first-page":"14","article-title":"Kleptomania, compulsive buying, and binge-eating disorder","volume":"56","author":"McElroy","year":"1995","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2008.01.008_bib62","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.4088\/JCP.v65n1104","article-title":"Topiramate in the long-term treatment of binge-eating disorder associated with obesity","volume":"65","author":"McElroy","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib63","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00213-003-1440-z","article-title":"Acute mania is accompanied by elevated glutamate\/glutamine levels within the left dorsolateral prefrontal cortex","volume":"168","author":"Michael","year":"2003","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib64","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/chi.0b013e31802f5f2c","article-title":"Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex","volume":"46","author":"Moore","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2008.01.008_bib65","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.schres.2004.02.016","article-title":"NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression, and bipolar disorder","volume":"71","author":"Mueller","year":"2004","journal-title":"Schizophr Res"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.jcp.0000270082.30500.69","article-title":"Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism","volume":"27","author":"Niederhofer","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"10.1016\/j.pnpbp.2008.01.008_bib67","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction in schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.01.008_bib68","first-page":"127","article-title":"The effect of NMDA antagonists on footshock-induced fighting behavior in chronically stressed rats","volume":"48","author":"Ossowska","year":"1997","journal-title":"J Physiol Pharmacol"},{"issue":"5","key":"10.1016\/j.pnpbp.2008.01.008_bib69","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/cap.2006.16.517","article-title":"A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders","volume":"16","author":"Owley","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib70","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.pnpbp.2006.04.013","article-title":"Memantine augmentation for refractory obsessive\u2013compulsive disorder","volume":"30","author":"Pasquini","year":"2006","journal-title":"Prog Neuro-Psychopharmacol & Biol Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2008.01.008_bib71","first-page":"65","article-title":"Glutamatergic dysfunction in obsessive\u2013compulsive disorder and the potential clinical utility of glutamate-modulating agents","volume":"13","author":"Pittenger","year":"2006","journal-title":"Primary Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib72","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/187152707780363267","article-title":"The NMDA receptor as a therapeutic target in major depressive disorder","volume":"6","author":"Pittenger","year":"2007","journal-title":"CNS & Neurol Disord \u2013 Drug Targets"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib73","first-page":"223","article-title":"Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test","volume":"51","author":"Popik","year":"1999","journal-title":"Pol J Pharmacol"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib74","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0091-3057(95)02163-9","article-title":"The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence","volume":"53","author":"Popik","year":"1996","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.01.008_bib75","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.npp.1300760","article-title":"Reinstatement of morphine-conditioned reward is blocked by memantine","volume":"31","author":"Popik","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.pnpbp.2008.01.008_bib76","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1176\/appi.ajp.162.11.2191-a","article-title":"Memantine for treatment-resistant OCD","volume":"162","author":"Poyurovsky","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib77","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0091-3057(91)90095-J","article-title":"Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin, or accumbens dopamine, but not caffeine","volume":"40","author":"Pulvirenti","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib78","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1176\/appi.ajp.161.4.662","article-title":"Linkage and association of the mitochondrial aspartate\/glutamate carrier SLC25A12 gene with autism","volume":"161","author":"Ramoz","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib79","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.npp.1300583","article-title":"Prolonged nicotine administration results in biphasic, brain-specific changes in kynurenate levels in the rat","volume":"30","author":"Rassoulpour","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib80","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1527-3458.2003.tb00254.x","article-title":"The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease","volume":"9","author":"Rogawski","year":"2003","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib81","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in forced swimming test in rats","volume":"42","author":"Rogoz","year":"2002","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.pnpbp.2008.01.008_bib82","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","article-title":"Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression","volume":"61","author":"Sanacora","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biopsych.2006.11.011","article-title":"Targeting an old mechanism in a new disease\u2013protection of glutamatergic dysfunction in depression","volume":"61","author":"Sattler","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib84","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1034\/j.1399-5618.2003.00024.x","article-title":"Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder","volume":"5","author":"Scarr","year":"2003","journal-title":"Bipolar Disord"},{"issue":"11","key":"10.1016\/j.pnpbp.2008.01.008_bib85","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1176\/appi.ajp.162.11.2182","article-title":"Confirmation of association between autism and the mitochondrial aspartate\/glutamate carrier SLC25A12 gene on chromosome 2q31","volume":"162","author":"Segurado","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.pnpbp.2008.01.008_bib86","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.pnpbp.2006.06.013","article-title":"Increased serum levels of glutamate in adult patients with autism","volume":"30","author":"Shinohe","year":"2006","journal-title":"Prog Neuro-Psychopharmacol & Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.01.008_bib87","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajmg.b.30025","article-title":"Family-based association study between autism and glutamate receptor 6 gene in Chinese Han trios","volume":"131","author":"Shuang","year":"2004","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib88","article-title":"Autism-related routines and rituals associated with a mitochondrial aspartate\/glutamate carrier SLC25A12 polymorphism","author":"Silverman","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib89","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1590\/S1516-44462006000300020","article-title":"Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder","volume":"28","author":"Teng","year":"2006","journal-title":"Rev Bras Psiquiatr"},{"issue":"12","key":"10.1016\/j.pnpbp.2008.01.008_bib90","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1176\/appi.ajp.160.12.2231","article-title":"Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS","volume":"160","author":"Theberge","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"11","key":"10.1016\/j.pnpbp.2008.01.008_bib91","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0\u00a0T proton MRS in never-treated patients with schizophrenia and healthy volunteers","volume":"159","author":"Theberge","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.01.008_bib92","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1176\/appi.ajp.162.3.626","article-title":"Memantine and catatonic schizophrenia","volume":"162","author":"Thomas","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib93","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00702-006-0570-y","article-title":"Memantine fails to facilitate partial cigarette deprivation in smokers\u2014no role of memantine in the treatment of nicotine dependency?","volume":"114","author":"Thuerauf","year":"2007","journal-title":"J Neural Transm"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib94","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/10298420290023954","article-title":"The neurobiology of opiate tolerance, dependence, and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity","volume":"4","author":"Trujillo","year":"2002","journal-title":"Neurotox Res"},{"issue":"4989","key":"10.1016\/j.pnpbp.2008.01.008_bib95","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.1824728","article-title":"Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801","volume":"251","author":"Trujillo","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib96","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.med.49.1.173","article-title":"The role of glutamatergic neurotransmission in the pathophysiology of alcoholism","volume":"49","author":"Tsai","year":"1998","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib97","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(92)90178-I","article-title":"Anxiolytic-like effects of the noncompetitive NMDA antagonist MK 801","volume":"43","author":"Xie","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.01.008_bib98","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.biopsych.2004.11.023","article-title":"An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression","volume":"57","author":"Zarate","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib99","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.01.008_bib100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind, placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"Zarate","year":"2006","journal-title":"Am J Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584608000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T22:48:11Z","timestamp":1684190891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584608000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0278584608000237"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2008.01.008","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}